Journal of Medical Virology

Article	Citations
Effect of the coronavirus pandemic on tumor markers	654
Epidemiology and genetic characterization of human metapneumovirus in pediatric patients from Hangzhou China	414
Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection	407
Aggregation of high‐frequency RBD mutations of SARS‐CoV‐2 with three VOCs did not cause significant antigenic drift	370
Human monkeypox outbreak in 2022	310
On the SARS‐CoV‐2 BA.2.75 variant: A genetic and structural point of view	281
Diversity of human sapovirus genotypes detected in Japanese pediatric patients with acute gastroenteritis, 2014–2017	229
A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID‐19 (SARS‐CoV‐2) pandemic	224
Factors associated with dexamethasone efficacy in COVID‐19. A retrospective investigative cohort study	220
Associations of human papillomavirus (HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city	210
Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model	187
Back Cover Image, Volume 95, Number 6, June 2023	183
Relationship between SARS‐CoV‐2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Paraná, Brazil	176
Maximal temperature varies by sex and ethnic group in hospital in‐patients with Covid‐19 infection	174
Comment on Higashimoto et al. “Analysis of the reliability of rapid diagnostic tests for varicella, including breakthrough cases”	167
	165
Antiviral therapy in DRESS	157
Clinical observation of neutralizing antibody DXP‐604 for treatment critical COVID‐19 patients infected with SARS‐CoV‐2 Delta variant	156
Rates and Factors Related to COVID‐19 Vaccine Uptake in Racialized and Indigenous Individuals in Canada: The Deleterious Effect of Experience of Racial Discrimination	153
Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B	130
Low Neutralization of SARS‐CoV‐2 Omicron BA5248, XBB15 and JN1 by Homologous Booster and Breakthrough Infection	129
Wild‐Type and rtA181T/sW172* Mutant Strains of Hepatitis B Virus Drive Hepatocarcinogenesis via Distinct GRP78‐Mediated ER Stress Pathways	126
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19	123
Vaccination hesitancy and the “myth” on mRNA‐based vaccines in Italy in the COVID‐19 era: Does urgency meet major safety criteria?	118
Strong association of functional polymorphism in IL‐12B with susceptibility to chronic hepatitis B in Tunisia	112

Evaluation of the late presentation and associated factors of people living with HIV in Turkey	102
The relationship between liver pathological inflammation degree and pyroptosis in chronic hepatitis B patients	102
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID‐19 patients	102
Gut microbiota dysbiosis is associated with sepsis‐induced cardiomyopathy in patients: A case‒control study	101
Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform	99
Does ACE2 mediate the detrimental effect of exposures related to COVID‐19 risk: A Mendelian randomization investigation	97
Mutations in SARS‐CoV‐2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure	96
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond	95
Genetic variability analysis of human papillomavirus 58: Novel sublineage identification and persistent infection association	95
A case of congenital human cytomegalovirus infection with placental and pulmonary calcification despite presence of intrauterine IgG	94
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2	93
Neutralizing antibody PR8‐23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin	90
Human monkeypox (hMPXV) re‐emergence: Host immunity status and current vaccines landscape	89
Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study	83
Adenovirus F41 infection and liver cytolysis in adult hematopoietic stem cell transplant recipients	82
COVID‐19 vaccination and decreased death rates: A county‐level study in Pennsylvania	80
Exploring the dynamics of the 2022 mpox outbreak in Canada	79
Real‐world effectiveness of Azvudine versus nirmatrelvir‐ritonavir in hospitalized patients with COVID‐19	78
mRNA‐HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV‐mediated cancers via subcutaneous immunization	75
5‐Nitrobenzo[c][1, 2, 5]selenadiazole as therapeutic agents in the regulation of oxidative stress and inflammation induced by influenza A(H1N1)pdm09 in vitro and in vivo	73
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies	72
Examination of control asymptomatic cohorts reveals heightened anti‐EBV and HHV‐6 A/B dUTPase antibodies in the aging populations	72
MORC3 restricts human cytomegalovirus infection by suppressing the major immediate‐early promoter activity	71
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections	70
Distribution of cervical intraepithelial neoplasia is closely associated with HPV status and uterine position	68
On the severity of COVID‐19 infections in 2021 in Italy	68
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma	67
Herpes simplex virus and SLE: Though uncommon yet with significant implications	67
Efficacy and safety of current treatment interventions for patients with severe COVID‐19 infection: A network meta‐analysis of randomized controlled trials	65
Exploring the mechanisms of long COVID: Insights from computational analysis of SARS‐CoV‐2 gene expression and symptom associations	65
Characterization of antibody‐dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes	64
Lack of monkeypox virus (MPXV) transmission despite occupational exposure of a large number of health care workers	63
SARS‐CoV‐2 NSP12 utilizes various host splicing factors for replication and splicing regulation	63
First wave of COVID‐19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases	63
A novel three‐plasmid packaging system for chimeric SFV/SIN VRPs derived from Semliki Forest virus and Sindbis virus as a candidate gene delivery vector	62
Inspiratory muscle training for COVID‐19: Benefits appear promising but findings remain uncertain	62
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV	61
Nobel calling Harald zur Hausen	61
Performance and feasibility of universal PCR admission screening for SARS‐CoV‐2 in a German tertiary care hospital	61
One dose versus two doses of COVID‐19 vaccine for the prevention of breakthrough infections among people previously infected with SARS‐Cov‐2	61
A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection	61
Sequencing on an imported case in China of COVID‐19 Delta variant emerging from India in a cargo ship in Zhoushan, China	61
Serum extracellular vesicle‐derived ASS1 is a promising predictor for the occurrence of HEV‐ALF	60
Coverage of Japanese encephalitis routine vaccination among children in central India	60
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico	59
Withdrawn: Anisodamine (654‐2) inhibits inflammation to alleviate influenza A virus‐induced acute lung injury	58
Detection of a novel species A, DS‐1‐like, G4P[6] rotavirus strain from a Brazilian child with gastroenteritis	58
Rapid immunoassay and clinical evaluation of the SARS‐CoV‐2 antibody assay on the real express‐6 analyzer	57
Evolution trace of SARS‐CoV‐2 from January 19 to March 12, 2020, in the United States	57
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy	57

	55
Medium‐term serostatus in Spanish case series recovered from SARS‐CoV‐2 infection	54
Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT‐PCR for SARS‐CoV‐2	54
Comparison of clinical characteristics of a patient with Epstein–Barr virus‐associated seizure and patients with COVID‐19‐associated seizure	54
Statistical modeling, dichotomization, and nonlinearity	54
Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping	53
	53
Assessment of alterations in the retina and vitreous in pre‐ and post‐COVID‐19 patients using swept‐source optical coherence tomography and angiography: A comparative study	53
Nasal mucosa is much more susceptible than oral mucosa to infection of SARS‐CoV‐2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used	53
Long‐term dynamic shifts in genomic base content and evolutionary trajectories of SARS‐CoV‐2 variants	53
“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies	53
First detection of SARS‐CoV‐2 BA.2.86.1 in Italy	51
Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study	51
Viral codon optimization on SARS‐CoV‐2 Spike boosts immunity in the development of COVID‐19 mRNA vaccines	51
Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma	51
Identification of a new polyomavirus in distinct human populations and tissues	50
A multicenter virome analysis of blood, feces, and saliva in myalgic encephalomyelitis/chronic fatigue syndrome	50
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients	50
Polymorphisms of RIG‐I‐like receptor influence HBV clearance in Chinese Han population	49
Mechanism of RNA m6A methylation modification regulating NLRP3 inflammasome activation for hand, foot, and mouth disease progression	48
Viral load: We need a new look at an old problem?	48
Long‐term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac‐inactivated booster: A 7‐month follow‐up study	47
Human parvovirus 4: An emerging etiological agent in cases presenting with influenza like illness	47
Serum thrombin‐activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever	47
Prevalence of drug resistant HIV‐1 forms in patients without any history of antiretroviral therapy in the Republic of Guinea	47
“Olfactory dysfunction in COVID‐19, new insights from a cohort of 353 patients: The ANOSVID study”: Author's reply	47
SARS‐CoV‐2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods	46
High detection rate of viral pathogens in nasal discharge in children aged 0 till 5 years	46
Persistent detection and sequencing of SARS‐CoV‐2 in the bloodstream of an immunocompromised patient	46
Rapid decrease of nasopharyngeal SARS‐CoV‐2 antigen in an outbreak of the Omicron strain	46
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort	45
Molecular characterization and risk factors of oral high‐risk human papillomavirus among females in Punjab, Pakistan	45
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children	45
Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination	45
A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super‐enhancers in maintaining EBV latency	44
Prepandemic viral community‐acquired pneumonia: Diagnostic sensitivity and specificity of nasopharyngeal swabs and performance of clinical severity scores	44
Evidence of Epstein‐Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder	44
Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měnglà virus with other filoviruses	43
A pyrosequencing protocol for rapid identification of SARS‐CoV‐2 variants	42
Diversity of picornaviruses detected in diarrheal samples from children in Belém, Brazilian Amazon (1982–2019)	42
Performance of a rapid antigen test in the diagnosis of SARS‐CoV‐2 infection	41
No signs of “tripledemic” in Finnish children	41
The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipients	41
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis	41
Severe influenza virus infection in children admitted to the PICU: Comparison of influenza A and influenza B virus infection	41
Prolonged presence of replication‐competent SARS‐CoV‐2 in mildly symptomatic individuals: A report of two cases	41
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries	41
Emerging Pteropine orthoreoviruses and their potential impact on public health	40
Need for polio eradication efforts in Pakistan: Where to focus	40
Issue Information	39
COVID‐19: A new risk factor or just a new imitator of preeclampsia? NLRP3 activation: A possible common mechanism	39
	39
Higher intensive care unit consultations for COVID‐19 patients living with HIV compared to those without HIV coinfection in Uganda	39
Various mpox recombinant subunits induce broadly reactive antibodies against orthopoxvirus in mice	38
Omicron variant genome evolution and phylogenetics	38
Protein arginine methyltransferase 5 mediates arginine symmetric dimethylation of influenza A virus PB2 and supports viral replication	38
Artificial intelligence for HPV status prediction based on disease‐specific images in head and neck cancer: A systematic review and meta‐analysis	38
Identification of a new 2‐amino acid insertion in the integrase coding region of HIV‐1 subtype G isolates	38
Genome‐based survey of the SARS‐CoV‐2 BF.7 variant from Asia	38
	38
Intricacies in characterizing positivity in pooled sample testing for SARS‐CoV‐2	38
SARS‐CoV‐2 and natural infection in animals	37
The SARS‐CoV‐2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10–19 years, middle‐aged males, or elderly individuals	37
A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) viruses	37
TRIM6 facilitates SARS‐CoV‐2 proliferation by catalyzing the K29‐typed ubiquitination of NP to enhance the ability to bind viral genomes	37
SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma	37
Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915‐918	37
Detection of SARS‐CoV‐2 virus in middle ear effusions and its association with otitis media with effusion	37
Dynamics of nasopharyngeal tract phageome and association with disease severity and age of patients during three waves of COVID‐19	37
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot study	37
	37
Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug‐resistant bacteria among COVID‐19 ICU patients from southwest Iran	36
The impact of the COVID‐19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China	36
Eliminating cervical cancer in China: Opportunities come and challenges remain	36
The effectiveness of active surveillance measures for COVID‐19 cases in Pudong New Area Shanghai, China, 2020	36
Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”	36
Epidemiology of cytomegalovirus infection in pregnancy in Israel: Real‐world data from a large healthcare organization	36
STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients receiving Peginterferon‐α therapy: A prospective cohort study in China	35
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS‐CoV‐2: A systematic review and meta‐analysis	35
The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID‐19 patients with malignancy: A single‐center experience	35

Lung–brain axis: Metabolomics and pathological changes in lungs and brain of respiratory syncytial virus‐infected mice	35
Being pregnant in the COVID‐19 pandemic: Effects on the placenta in all aspects	35
The diversity in the clinical features of children hospitalized with COVID‐19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV‐2: Caution	35
Molecular epidemiology and characterization of enteroviruses detected in cerebrospinal fluid and respiratory samples in Slovenia, 2014–2023	34
QuantiFERON‐CMV and monitor predict cytomegalovirus, mortality, and graft‐versus‐host disease in transplant recipients	34
Immunogenicity and safety of an inactivated SARS‐CoV‐2 vaccine in people living with HIV: A cross‐sectional study	34
Performance analysis of mathematical methods used to forecast the 2022 New York City Mpox outbreak	34
Hypoxia and hypoxia‐inducible factors in Kaposi sarcoma‐associated herpesvirus infection and disease pathogenesis	34
Detection of lumpy skin disease virus reads in the human upper respiratory tract microbiome requires further investigation	34
Prevalence and factors related to COVID‐19 vaccine hesitancy and unwillingness in Canada: A systematic review and meta‐analysis	34
Discovery of a small‐molecule inhibitor targeting the ovarian tumor domain of a novel Tamdy orthonairoviruse associated with human febrile illness	34
Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2	33
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review	33
Comparison of epidemiological characteristics between hemorrhagic fever with renal syndrome patients and severe fever with thrombocytopenia syndrome patients	33
Epidemiology of the resurgence of respiratory syncytial virus infections among children post‐COVID‐19: A single‐center retrospective observational study	33
Proximity ligation‐based sequencing for the identification of human papillomavirus genomic integration sites in formalin‐fixed paraffin embedded oropharyngeal squamous cell carcinomas	32
Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic	32
Unreliable predictions about COVID‐19 infections and hospitalizations make people worry: The case of Italy	32
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults	32
Anal and oropharyngeal HPV distribution in HIV‐negative multipartner MSM using self‐sampling kits for HIV and sexually transmitted infection screening	32
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections	32
	32
Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea	32
Antibody response following the fourth SARS‐CoV‐2 vaccine dose during the Omicron wave in Brazil	31
Issue Information	31
Phylogenetic analysis of BKV genetic variations, based on the whole sequence of the genome and different genomic sections	31
Prior immunosuppressive therapy is associated with mortality in COVID‐19 patients: A retrospective study of 835 patients	31
A fatal case of Crimean‐Congo hemorrhagic fever from Kutch, Gujarat, India 2023	31
Incidence of sexually transmitted hepatitis C virus infection among men who have sex with men in Japan from 2009 to 2023	31
Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020	31
TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population	31
	31
BK polyomavirus in Iranian patients with papillary thyroid cancer: Is it a major future challenge?	31
Postvaccination SARS‐CoV‐2 Alpha (B.1.1.7) lineage infection among healthcare workers on the background of IgG antibodies	31
Molecular evolution and antigenic drift of type 3 iVDPVs excreted from a patient with immunodeficiency in Ningxia, China	31
Predicting the negative conversion time of nonsevere COVID‐19 patients using machine learning methods	30
Immunogenicity and safety of inactivated SARS‐CoV‐2 vaccines in people living with HIV: A longitudinal cohort study	30
Reactivation or reinfection of COVID‑19 disease?	30
Craniofacial pain in COVID‐19 patients with diabetes mellitus: Clinical and laboratory description of 21 cases	30
Autoantibodies against angiotensin‐converting enzyme 2 (ACE2) after COVID‐19 infection or vaccination	30
COVID‐19 and Tuberculosis overlapping epidemics: A holistic review from Pakistan	30
The potential rationale of COVID‐19 vaccine‐induced myopericarditis	30
Genotyping and sequence characterization of the NSP4 gene of human group A rotavirus strains in Northern Iran	30
Trends in the morbidity and mortality of coronavirus disease 2019 in different ethnic groups and gender in a large Brazilian city	30
Assessing risk factors for COVID‐19 pneumonia in Chinese patients with pre‐existing interstitial lung disease	30
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID‐19 pneumonia	30
	30
The association between famotidine and in‐hospital mortality of patients with COVID‐19	30
Bioinformatics analysis of the s2m mutations within the SARS‐CoV‐2 Omicron lineages	29
Assessment of immunity against Yellow Fever virus infections in northeastern Nigeria using three serological assays	29
Immune landscape of viral cancers: Insights from single‐cell sequencing	29
A significant predictor of in‐hospital and long‐term mortality and progression in COVID‐19 patients: The end‐stage liver disease (MELD) score model	29
Cover Image, Volume 94, Number 10, October 2022	29
The whole‐genome sequencing of prevalent DENV‐1 strains during the largest dengue virus outbreak in Xishuangbanna Dai autonomous prefecture in 2019	29
Issue Information	29
Rhinoviruses A and C elicit long‐lasting antibody responses with limited cross‐neutralization	29
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples	29
Evaluating agreement in different diagnosis methods is necessary	29
Monkeypox virus: A sexual transmission and beyond	28
Survival of SARS‐CoV‐2 in artificial seawater and on the surface of inanimate materials	28
NAC1 confines virus‐specific memory formation of CD4+ T cells through the ROCK1‐mediated pathway	28
Evaluation of 3‐month follow‐up of patients with postacute COVID‐19 syndrome	28
Neutralization of distinct Omicron sublineages by longitudinal vaccination sera	28
Global and regional estimates of cervical cancer burden associated with human immunodeficiency virus infection from 1990 to 2019	28
Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period	28
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial	28
Mutational and phylogenetic analyses of the two lineages of the Omicron variant	28
Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019	28
Quantitative assessment of SARS‐CoV‐2 RNAemia and outcome in patients with coronavirus disease 2019	28
The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis	28
Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report	27
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study	27
Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019	27
Repurposing of the antibiotic nitroxoline for the treatment of mpox	27
Pityriasis rosea during COVID‐19: Pathogenesis, diagnosis, and treatment	27
A cross‐sectional study of SARS‐CoV‐2 seropositivity among healthcare workers and residents of long‐term facilities in Italy, January 2021	27
What is the true place of the SARS‐CoV‐2 rapid point‐of‐care antigen test in the hospital setting? Lessons learned from real life	27
Peripheral blood parameters for predicting PICU admission and mechanical ventilation in pediatric inpatients with human parainfluenza virus‐induced pneumonia	27
The acceptance of SARS‐CoV‐2 rapid antigen self‐testing: A cross‐sectional study in China	27
European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test	27
Amplicon size and non‐encapsidated DNA fragments define plasma cytomegalovirus DNA loads by automated nucleic acid testing platforms: A marker of viral cytopathology?	27
Chickenpox and multiple sclerosis: A Mendelian randomization study	26
SARS‐CoV‐2 ORF3a inhibits cGAS‐STING‐mediated autophagy flux and antiviral function	26
Mpox virus Clade IIb detection in the air	26
Comment on “A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination”	26
Assessing the risks associated with the emergence of Florona and possible preventive measures	26
Anti‐SARS‐CoV‐2 IgG levels in relation to disease severity of COVID‐19	26
Herpes zoster ophthalmicus in two women after Pfizer–BioNTech (BNT162b2) vaccine	26
Different species of Chiroptera: Immune cells and molecules	26
Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France	26
Evaluation of the relationship between KIM‐1 and suPAR levels and clinical severity in COVID‐19 patients: A different perspective on suPAR	26
New SARS‐CoV‐2 variant of concern imported from the United Kingdom to Vietnam, December 2020	26
Previous SARS‐CoV‐2 infection is linked to lower vaccination intentions	26
Cross‐immunity and trained immunity in explaining variable COVID‐19 mortality—Guidance for future pandemics	25
Chelsea physical assessment tool for evaluating functioning in post‐intensive care unit COVID‐19 patients	25